Palantir’s post-Q2 earnings momentum, including 93% year-over-year revenue growth to $1.94 billion and a raised full-year 2026 target of $8.15 billion, combined with new government contracts such as the $48.1 million U.S. Army ammunition-management deal, has driven the share price to recent highs near $192–194. U.S. commercial revenue surged 149% in the quarter while operating margins expanded sharply, reinforcing trader focus on AI platform adoption and expanding deal flow. With the stock trading around $189–190 as of September 25 amid elevated valuation multiples above 160 times earnings, the tight clustering of market-implied odds around the $192–196 bins reflects both continued momentum from analyst upgrades and partnerships and countervailing concerns over profit-taking or broader tech rotation that could influence the week-of-September-28 close.